Hualan Biological Engineering Inc

002007

Company Profile

  • Business description

    Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, recombinant proteins, and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin, and others. The vaccine products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine, and others. It also offers gene products such as Monoclonal Antibodies for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.

  • Contact

    No. 1, Hualan Avenue
    Henan Province
    Xinxiang453003
    CHN

    T: +86 3733559989

    http://www.hualanbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    4,117

Stocks News & Analysis

stocks

Sales shine but broader macro outlook darkens for this ASX share

US stores are struggling, but our investment thesis hinges on the Australian rollout.
stocks

Chart of the Week: US equity market trading at an attractive discount

The latest from our Chief US Market Strategist.
stocks

Undervalued ASX share retains wide moat rating despite regulatory pressures

Proposed price regulation impacts our fair value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,168.9043.800.48%
CAC 408,263.87355.134.49%
DAX 4024,080.631,159.045.06%
Dow JONES (US)47,909.921,325.462.85%
FTSE 10010,608.88260.092.51%
HKSE25,775.70117.32-0.45%
NASDAQ22,634.99617.142.80%
Nikkei 22555,895.32413.10-0.73%
NZX 50 Index13,273.8119.870.15%
S&P 5006,782.81165.962.51%
S&P/ASX 2008,973.2057.800.65%
SSE Composite Index3,966.0128.98-0.73%

Market Movers